Wakimoto, H., Tanaka, S., Curry, W. T., Loebel, F., Zhao, D., Tateishi, K., . . . Chi, A. S. (2014). Targetable signaling pathway mutations are associated with malignant phenotype in IDH-mutant gliomas.
Citación estilo ChicagoWakimoto, Hiroaki, et al. Targetable Signaling Pathway Mutations Are Associated With Malignant Phenotype in IDH-mutant Gliomas. 2014.
Cita MLAWakimoto, Hiroaki, et al. Targetable Signaling Pathway Mutations Are Associated With Malignant Phenotype in IDH-mutant Gliomas. 2014.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.